| scholarly article | Q13442814 |
| P50 | author | Dipen Patel | Q99593426 |
| Sonya J Snedecor | Q118489410 | ||
| P2093 | author name string | Marguerite McDonald | |
| Michael S Keith | |||
| P2860 | cites work | Prevalence of dry eye syndrome among US women | Q28196875 |
| A SELF-RATING DEPRESSION SCALE | Q28201088 | ||
| A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale | Q28256570 | ||
| EuroQol--a new facility for the measurement of health-related quality of life | Q29547873 | ||
| Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome | Q33578726 | ||
| Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies | Q33720070 | ||
| Development of the 25-item National Eye Institute Visual Function Questionnaire | Q34083677 | ||
| EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome | Q34117422 | ||
| The economic burden of dry eye disease in the United States: a decision tree analysis | Q34147677 | ||
| Dry eye medication use and expenditures: data from the medical expenditure panel survey 2001 to 2006. | Q34380941 | ||
| A Rating Instrument For Anxiety Disorders | Q34701881 | ||
| The international workshop on meibomian gland dysfunction: introduction | Q34769291 | ||
| Prevalence and risk factors associated with dry eye symptoms: a population based study in Indonesia. | Q35006592 | ||
| Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients | Q35717311 | ||
| Impact of dry eye syndrome on vision-related quality of life | Q35741609 | ||
| Dry eye: diagnosis and current treatment strategies | Q35790953 | ||
| Annual direct cost of dry eye in Japan | Q35997499 | ||
| Impact of dry eye on work productivity | Q36317967 | ||
| Conventional therapy of Sjogren's syndrome | Q36997278 | ||
| Etiology, prevalence, and treatment of dry eye disease | Q37288773 | ||
| EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome | Q37846349 | ||
| Measures of functional status and quality of life in rheumatoid arthritis: Health Assessment Questionnaire Disability Index (HAQ), Modified Health Assessment Questionnaire (MHAQ), Multidimensional Health Assessment Questionnaire (MDHAQ), Health Asse | Q38010367 | ||
| Results of a population-based questionnaire on the symptoms and lifestyles associated with dry eye. | Q39437533 | ||
| Association between depression and dry eye disease in an elderly population | Q39997747 | ||
| Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain | Q40026647 | ||
| Differential diagnosis of dry eye conditions | Q41231731 | ||
| Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome | Q42940964 | ||
| Dry eye disease, dry eye symptoms and depression: the Beijing Eye Study | Q43448087 | ||
| Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications | Q43482891 | ||
| Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome | Q44006693 | ||
| The impact of dry eye disease on visual performance while driving | Q44025895 | ||
| Androgen control of gene expression in the rabbit meibomian gland. | Q44339203 | ||
| Validity of the Hospital Anxiety and Depression Scale to assess depression and anxiety following traumatic brain injury as compared with the Structured Clinical Interview for DSM-IV. | Q44368638 | ||
| Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study. | Q44473550 | ||
| Impaired functional status in primary Sjögren's syndrome | Q44473952 | ||
| The Relationship between Habitual Patient-Reported Symptoms and Clinical Signs among Patients with Dry Eye of Varying Severity | Q44631963 | ||
| The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group | Q47344740 | ||
| Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease | Q47755532 | ||
| Tear film osmolarity measurements in dry eye disease using electrical impedance technology | Q48222071 | ||
| The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists. | Q50786223 | ||
| Clinically important difference in dry eye: change in IDEEL-symptom bother. | Q51690478 | ||
| The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. | Q51934443 | ||
| Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool. | Q51942190 | ||
| The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. | Q52037688 | ||
| Utility assessment among patients with dry eye disease. | Q53379868 | ||
| Health-related quality of life in patients with primary Sjögren's syndrome and xerostomia: a comparative study. | Q53423349 | ||
| Reliability and validity of the Ocular Surface Disease Index | Q73801624 | ||
| Performance and repeatability of the NEI-VFQ-25 in patients with dry eye | Q74492517 | ||
| The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) | Q80347907 | ||
| The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007) | Q80347909 | ||
| UK patients with primary Sjögren's syndrome are at increased risk from clinical depression | Q80567002 | ||
| The economic burden of dry eye: a conceptual framework and preliminary assessment | Q80902614 | ||
| Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye | Q81603538 | ||
| Work productivity loss in patients with dry eye disease: an online survey | Q83645366 | ||
| Prevalence of dry eye syndrome in an adult population | Q87221342 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | literature review | Q2412849 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 144-67 | |
| P577 | publication date | 2016-04-01 | |
| P1433 | published in | The Ocular Surface | Q15764153 |
| P1476 | title | Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature Review | |
| P478 | volume | 14 |
| Q41442733 | A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment |
| Q91906669 | A comparative study of the quality of non-stimulated and stimulated tears in normal eye male subjects using the tear ferning test |
| Q64226436 | A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease |
| Q64900873 | Characteristics of Individuals with Dry Eye Symptoms Without Clinical Diagnosis: Analysis of a Web-Based Survey. |
| Q91811467 | Contribution of Mucins towards the Physical Properties of the Tear Film: A Modern Update |
| Q57378488 | Current and emerging therapy of dry eye disease. Part A: pharmacological modalities |
| Q90451538 | Disease aetiology-based design of multifunctional microemulsion eye drops for moderate or severe dry eye: a randomized, quadruple-masked and active-controlled clinical trial |
| Q61802909 | Dry eye disease ranking among common reasons for seeking eye care in a large US claims database |
| Q47639135 | Dry eye syndrome: developments and lifitegrast in perspective |
| Q90640187 | Effects of Lipid Saturation on the Surface Properties of Human Meibum Films |
| Q92507140 | Evaluating Patient Experiences in Dry Eye Disease Through Social Media Listening Research |
| Q99636426 | Eye health and quality of life: an umbrella review protocol |
| Q91627585 | Eyelid margin cleaning using Deep Cleaning Device for the treatment of meibomian gland dysfunction-associated dry eye: a preliminary investigation |
| Q90397191 | Influence of eyelid pigmentation on the diagnosis of meibomian gland dysfunction |
| Q39025675 | LFA-1/ICAM-1 Interaction as a Therapeutic Target in Dry Eye Disease |
| Q38608475 | Lifitegrast for the treatment of dry eye disease in adults |
| Q37399828 | Lipoxin A4 Counter-regulates Histamine-stimulated Glycoconjugate Secretion in Conjunctival Goblet Cells |
| Q47239843 | Noninvasive Electrical Stimulation for the Treatment of Chronic Ocular Pain and Photophobia. |
| Q89782794 | Novel Sustained-Release Drug Delivery System for Dry Eye Therapy by Rebamipide Nanoparticles |
| Q91905513 | Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease |
| Q64244731 | Prevalence and Determinants of Dry Eye Disease among 40 Years and Older Population of Riyadh (Except Capital), Saudi Arabia |
| Q90233774 | Progesterone Application to the Rat Forehead Produces Corneal Antinociception |
| Q52661549 | Reflections on Dry Eye Syndrome Treatment: Therapeutic Role of Blood Products. |
| Q90249521 | Resolvin D1, but not resolvin E1, transactivates the epidermal growth factor receptor to increase intracellular calcium and glycoconjugate secretion in rat and human conjunctival goblet cells |
| Q49594250 | Satisfaction and convenience of using terpenoid-impregnated eyelid wipes and teaching method in people without blepharitis. |
| Q38674125 | Surface Chemistry Interactions of Cationorm with Films by Human Meibum and Tear Film Compounds |
| Q92372126 | Tear Metabolomics in Dry Eye Disease: A Review |
| Q50025206 | Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program. |
| Q60946811 | What's new in dry eye disease diagnosis? Current advances and challenges |
| P3431 | Publons publication ID | Wikidata property example | P1855 |
Search more.